Polyvalent pneumococcal vaccine

Known as: PPSV, Pneumococcal Polysaccharide Vaccine [Chemical/Ingredient], Pneumococcal Polyvalent Vaccine 
An polyvalent vaccine used to prevent infection by the bacterium Streptococcus pneumoniae. Pneumococcal polyvalent vaccine contains highly purified… (More)
National Institutes of Health

Related topics

Related topics

12 relations
23-valent pneumococcal capsular polysaccharide vaccineCommunicable DiseasesDrug AllergyHodgkin Disease
(More)

Broader (1)

Pneumococcal vaccine

Narrower (1)

Pneumovax 23

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization
INTRODUCTION The WHO recommends annual influenza vaccination to prevent influenza illness in high-risk groups. Little is known… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Review
2016
Review
2016
A Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein Antigens.
This review describes development of currently available pneumococcal vaccines, provides summary tables of current pneumococcal… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years : global estimates
Background Streptococcus pneumoniae is a leading cause of bacterial pneumonia, meningitis, and sepsis in children worldwide… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.
BACKGROUND Changes in invasive pneumococcal disease (IPD) incidence were evaluated after 7 years of 7-valent pneumococcal… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Vaccine Escape Recombinants Emerge after Pneumococcal Vaccination in the United States
The heptavalent pneumococcal conjugate vaccine (PCV7) was introduced in the United States (US) in 2000 and has significantly… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.
OBJECTIVE To monitor clinical and microbiologic features including antimicrobial susceptibility and serogroup distribution of… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
BACKGROUND In early 2000, a protein-polysaccharide conjugate vaccine targeting seven pneumococcal serotypes was licensed in the… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
BACKGROUND Ear infections are a common cause of illness during the first two years of life. New conjugate vaccines may be able to… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations.
OBJECTIVE To determine pneumococcal polysaccharide vaccine efficacy in selected populations at risk for serious pneumococcal… (More)
Is this relevant?
Highly Cited
1991
Highly Cited
1991
The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.
BACKGROUND Although the protective efficacy of pneumococcal polysaccharide vaccine has been demonstrated in randomized trials in… (More)
Is this relevant?